Selected compounds for targeted degradation of BRD9

A method for the treatment of a cancer mediated by BRD9 in a human, comprising administering to the human an effective amount of a compound of Formula:

• or a pharmaceutically acceptable salt thereof, wherein the cancer is an epithelioid malignant peripheral nerve sheath tumor, schwannomas in familial schwannomatosis, atypical malignant teratoid rhabdoid tumor, or cribriform neuroepithelial tumor.

A method for preventing the recurrence of a BRD9 mediated disorder in a human comprising administering to the human an effective amount of a compound of Formula:

• or a pharmaceutically acceptable salt thereof.